Original document(26 pages)  中文版
    Compounds of formula (I) in free or salt form, wherein T, X, Y, U, R<1>, R<2>,< >m, n and p have the meanings as indicated in the specification, are useful for treating conditions mediated by CCR3. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
Application Number
申请号		 200580002605 Application Date
申请日		 2005.01.28
Title 名称 Pyrrolidine derivatives acting as CCR3-receptor antagonists
Publication Number
公开号		 1910145 Publication Date
公开日		 2007.02.07
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D207/12;A61K31/4015;A61P11/06
Applicant(s) Name
申请人		 Novartis AG
Address 地址
Inventor(s) Name 发明人 Bhalay Gurdip;Dunstan Andrew;Glen Angela;Howe Trevor John;Mccarthy Clive
Attorney & Agent 代理人 huang gesheng sui xiaobeng
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.